Pain management is a competitive vertical with a peculiar structure: the patients searching for "radiofrequency ablation near me" or "spinal cord stimulator" are often simultaneously being routed through referral channels by PCPs and orthopedists. That dual-funnel reality — direct-to-patient search and physician referral — means your competitive landscape isn't a single battlefield. It's at least three overlapping ones, and most practices only see the one they're standing on.
Understanding who actually competes for your procedural volume, what they spend to acquire it, and where they leave gaps requires separating signal from noise in a way that's specific to interventional pain.
The Three Competitor Types Bidding Against Your Epidural and RFA Pages
Your true paid-acquisition competitors for searches like "epidural steroid injection," "nerve block near me," or "facet joint injection" fall into distinct categories:
Hospital-owned pain programs. These are your heaviest-spending rivals. Health systems bid on procedure-intent terms with deep budgets, often routing clicks to generic "pain management" pages that bury the specific procedure three clicks deep. Their advantage is brand trust. Their weakness is specificity — a patient searching "medial branch block" lands on a page about "comprehensive pain care" and bounces.
Private interventional practices (your direct peers). Fellowship-trained physicians running independent or small-group practices. These operators bid on the same procedure terms you do, often with tighter geographic targeting. They're your real competition for the patient who has already decided they want an interventional approach.
Multidisciplinary pain clinics and PM&R groups. These practices blend physical medicine, medication management, and some procedures. They bid on condition-intent terms ("back pain treatment," "sciatica relief") more than procedure-intent terms. They compete for the earlier-stage patient who hasn't yet committed to an interventional path.
Referral-Channel Competitors Don't Show Up in Your Auction — But They Take Your Volume
A significant portion of your epidural, nerve block, and spinal cord stimulation volume arrives through referring physicians. The orthopedist who sends post-surgical patients for pain blocks, the PCP who refers chronic low-back patients for RFA evaluation — these referral relationships don't appear in your Google Ads auction data, but they determine where patients end up.
Your referral-channel competitors are other interventional practices with stronger relationships to the same referring physicians. They don't outbid you on "sacroiliac joint injection." They simply receive the patient before that patient ever searches.
This matters for competitive intelligence because it means your paid-search data only shows you part of the competitive picture. A practice that appears to have minimal digital presence may still be capturing high-value neuromodulation cases (spinal cord stimulation trials, intrathecal pump implants) entirely through orthopedic and neurosurgery referral networks.
The SERP Noise That Pollutes Your Competitive View: Medtronic, Nevro, and Directory Clutter
When you search "spinal cord stimulator" or "intrathecal pump," you'll see manufacturer sites — Medtronic, Abbott, Nevro, Boston Scientific, Flowonix — dominating organic positions. These aren't your competitors for patients. They're device manufacturers running awareness campaigns that actually create demand you can capture.
Similarly, directory listings (Healthgrades, Zocdoc, Vitals) and content aggregators (WebMD, Spine-Health) occupy organic real estate for searches like "trigger point injection" and "stellate ganglion block." They're not bidding against you in paid search, but they absorb organic clicks that could otherwise reach your practice pages.
The competitive intelligence mistake: treating these as rivals. They're terrain features, not opponents. Your strategy should account for them (you won't outrank Medtronic organically for "spinal cord stimulation") without wasting energy competing against them.
Searches No Competitor Answers Well — The Gaps in Pain Management SERPs
Here's where competitive intelligence becomes actionable. Certain high-intent searches in interventional pain are consistently under-served by local competitors:
Procedure-plus-condition combinations. Patients search "radiofrequency ablation for SI joint pain" or "nerve block for occipital neuralgia" — combining a procedure they've researched with their specific diagnosis. Most competitor pages address either the procedure OR the condition, rarely both on a single dedicated page.
Trial and evaluation searches. "SCS trial what to expect," "spinal cord stimulator trial process," "how long is a pain pump trial" — these represent patients deep in the decision funnel for your highest-value procedures. Few local practices build content that answers these searches. The results are dominated by manufacturer sites and national health content publishers.
Comparison and alternative searches. "Epidural vs nerve block," "radiofrequency ablation vs steroid injection," "spinal cord stimulator vs pain pump" — patients comparing interventional options. These searches reveal a patient who has committed to a procedural approach and is evaluating which one. Almost no local practice builds pages addressing these comparisons.
Post-procedure and follow-up searches. "How long does a facet joint injection last," "RFA recovery time," "medial branch block didn't work" — these aren't acquisition searches in the traditional sense, but they represent patients who may need repeat procedures or escalation to more advanced interventions (the patient whose medial branch block diagnostic was positive is your next RFA case).
Cash-Pay Regenerative Searches Exist in a Separate Competitive Universe
PRP injections, biologic joint injections, and other regenerative services that fall outside insurance coverage attract a fundamentally different competitor set. Here, you're competing against:
These competitors bid on terms like "PRP injection for knee" or "stem cell therapy for back pain" with landing pages that often make claims you cannot (and should not) make given regulatory constraints around biologics, cellular therapies, and the 361/351 classification framework.
Your competitive advantage here is credibility — fellowship training, image-guided technique, and the clinical infrastructure to offer PRP as part of a broader interventional continuum rather than as a standalone cash-grab service. But you need dedicated campaigns for these services, structurally separated from your insurance-covered procedural campaigns, with different CPAs, different landing pages, and different competitive positioning.
Your Highest-Value Procedures Have the Thinnest Local Competition
Spinal cord stimulation and intrathecal pump management represent the highest lifetime patient value in interventional pain. A single SCS trial that converts to permanent implant generates substantial revenue across the trial, implant, and years of follow-up programming visits.
Yet in most local markets, very few practices run dedicated paid campaigns for "spinal cord stimulator" or "pain pump." The competition for these terms is disproportionately low relative to their value. Why? Because most practices acquire these patients through referral channels and don't think to bid on direct-to-patient search terms for neuromodulation.
This is a concrete, exploitable gap. The patient searching "spinal cord stimulator for CRPS" or "failed back surgery pain pump" has already been educated (often by Medtronic or Nevro's own awareness campaigns) and is actively seeking a provider. If you're not visible for that search, a hospital program or a competitor two zip codes away captures that case.
The Negative Keyword Problem Is Uniquely Severe in Pain Management
No other procedural vertical has the pollution problem that pain management does. Searches containing "pain" attract opioid-related queries, addiction treatment searches, legal/malpractice traffic, and job seekers (fellowship, salary, hiring). Without aggressive negative keyword architecture — excluding terms like "suboxone," "methadone," "rehab," "detox," "lawsuit," "attorney," "fellowship," "residency," "coding," "billing" — your campaigns bleed budget on clicks that will never convert to a patient scheduling an epidural or nerve block.
Your competitors who don't maintain rigorous negative keyword lists are effectively subsidizing irrelevant traffic. That's their waste — and your opportunity to achieve lower effective cost-per-acquisition by running cleaner campaigns on the same procedure-intent terms.
What Competitive Gaps Actually Look Like for an Interventional Pain Practice
The actionable gaps aren't theoretical. They're structural:
1. Procedure-specific landing pages that match the exact search ("sacroiliac joint injection" deserves its own page, not a bullet point on a "services" page) — most competitors consolidate.
2. Neuromodulation campaigns targeting direct-to-patient search for spinal cord stimulation and intrathecal pumps — most competitors rely solely on referrals.
3. Comparison content addressing "epidural vs. RFA" or "nerve block vs. surgery" — almost universally absent from local practice sites.
4. B2B campaigns targeting referring physicians with messaging about your specific capabilities (fluoroscopic guidance, neuromodulation programming, complex implant revision) — a channel most competitors ignore in digital.
5. Cash-pay regenerative campaigns structurally separated from insurance-covered procedural campaigns, with landing pages that emphasize fellowship credentials and image-guided technique to differentiate from the non-physician regenerative clinics bidding on the same terms.
The practices that capture disproportionate volume in interventional pain aren't necessarily spending more. They're spending on the right procedure-intent terms, with pages that match, in auctions their competitors haven't entered.
By Todd Whitaker, MBA
A free market analysis shows you exactly which competitors are bidding on interventional pain searches in your area, what they're paying, and where the gaps are in your specific market. Get your free market analysis